Importantly, the authors reported that MOR was downregulated in the lesional skin of AD patients; however, they did not investigate sex-, age- and region-matched skin specimens from healthy subjects simultaneously in the same staining procedure, leaving the degree of actual decrease questionable. This evidence concerns the gene OPRM1 and Alzheimer disease.